HANNAH HANEBRINK: Open Payments
NPI 1689455024 · COLUMBIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 35 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $2,919 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $67 |
| Amgen Inc. | 3 | $59 |
| Novo Nordisk Inc | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Axsome Therapeutics, Inc. | 2 | $34 |
Products named: MOUNJARO, OTEZLA, REXULTI, VRAYLAR, CAPLYTA, SPRAVATO, FANAPT, Ozempic.
Industry payments across IL — which companies pay providers there.
